Skip to content

News

Now Accepting Applications for 2017 Community Partners

Now Accepting Applications for 2017 Community Partners

OCRFA’s Community Partners (formerly called Partner Members) are outstanding grassroots, local and national organizations around the country who share a commitment to eradicate ovarian cancer through research, advocacy, support, education and awareness. The goal of our Community Partners initiative is to unite the ovarian cancer community into a national movement speaking with one voice through … Continued

Community

Now Accepting Scholarship Applications for 2017 Ovarian Can...

Now Accepting Scholarship Applications for 2017 Ovarian Cancer National Conference

Update: The 2017 Scholarship Application closed on April 2, 2017. Our scholarship program allows patients and caregivers to learn about ovarian cancer and connect with others who share their experiences. In 2016, thanks to the generosity of donors, our scholarship program helped 40 individuals attend our National Conference. A limited number of scholarships for registration … Continued

Community

Give today to invest in tomorrow’s cure.

Give today to invest in tomorrow’s cure.

Time is running out to make your tax-deductible 2016 gift to OCRFA. We need your help. Over 22,000 women will be diagnosed with ovarian cancer in 2017. Over 200,000 women are currently living with ovarian cancer. Your support will make a big difference in the lives of these women and their families. Ovarian cancer is … Continued

OCRA News

Fighting Ovarian Cancer Through Patient Support and Education

Fighting Ovarian Cancer Through Patient Support and Education

Every year, 22,000 women are newly diagnosed with ovarian cancer. As OCRFA strives toward a cure and better treatments through research, we also provide patients and survivors with the care they need through our support and education programs. Now in 29 sites across the country, our Woman to Woman program has impacted over 400 women, … Continued

Community

Some Fallopian Tube Lesions Represent Ovarian Cancer Metast...

Some Fallopian Tube Lesions Represent Ovarian Cancer Metastases, Not Precursor Lesions

(Dec. 21, 2016) Research published recently in Cancer Discovery suggests that cells in the fallopian tube previously thought to be precursors to high grade serous ovarian cancer may sometimes be cells that have metastasized and implanted into the fallopian tube. The research was conducted by a team at the University of Chicago under the guidance … Continued

Research

Rucaparib FDA Approved for Advanced Ovarian Cancer with BRC...

Rucaparib FDA Approved for Advanced Ovarian Cancer with BRCA Mutations

(Dec. 19, 2016) The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have a specific gene mutation (deleterious BRCA) as … Continued

Research

Federal Funding for Ovarian Cancer: 2016 Highlights

Federal Funding for Ovarian Cancer: 2016 Highlights

As the voice for women with ovarian cancer on Capitol Hill, OCRFA fights to secure funding for ovarian cancer research and education at the federal level. In 2016, with the help of committed Advocate Leaders, Grassroots Advocates, Research Advocates and action alert supporters, OCRFA was able to: We’ve made great strides in ensuring that ovarian … Continued

Advocacy

Five Important Discoveries from OCRFA-Funded Researchers in...

Five Important Discoveries from OCRFA-Funded Researchers in 2016

OCRFA-funded scientists are working hard to save women’s lives. In medical institutions across the country, they investigate the origins and biology of ovarian cancer, find new ways to identify and prevent the disease, and discover better treatments. In 2016, our grantees made significant advances in the fight against ovarian cancer, including: Progress is being made … Continued

OCRA News

Turn Up the Heat Tickets Now Available

Turn Up the Heat Tickets Now Available

Tickets are now available for the 2017 Turn Up the Heat! Gala in Washington DC. Turn Up the Heat features food from the top female chefs in DC and the surrounding area! Join us on February 22nd for a night full of delicious food and great company. Get your tickets at www.turnuptheheatgala.org

Events

Kolker Fellowship Deadline Approaching

Kolker Fellowship Deadline Approaching

The Kolker Fellowship commemorates the legacy of pioneering health policy advocate Ann Kolker. At the time Ann was diagnosed with ovarian cancer in 1996, she was already a political powerhouse, having early involvement with organizations like the National Women’s Political Caucus and Emily’s List. We are now accepting applications for the Fall 2017 Fellowship.

Advocacy

FDA Approves Avastin for Platinum-Sensitive Recurrent Ovari...

FDA Approves Avastin for Platinum-Sensitive Recurrent Ovarian Cancer

(Dec. 9, 2016) This week Genentech announced that the US Food and Drug Administration has expanded approval for bevacizumab (Avastin) to include patients with platinum-sensitive, recurrent disease, either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by Avastin alone. The approval is based on two large Phase III … Continued

Research

Managing Recurrence: What You Need to Know (Webinar Available)

Managing Recurrence: What You Need to Know (Webinar Available)

Recurrence is in the back of every ovarian cancer survivor’s mind. In this presentation, originally broadcast on November 28, 2016, Dr. Sarah Adams provided an overview of strategies for managing recurrent ovarian cancer, discussing the goals of treatment during recurrence, typical courses of treatment, and advice on how to approach making decisions about treatment during … Continued

Information

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.